Sulfatide-containing liposomal doxorubicin produced more reduction in tumor volume.
- Jia Lin (121865)
- Yan Yu (56143)
- Sarah Shigdar (121869)
- Ding Zhi Fang (121875)
- Jun Rong Du (121878)
- Ming Q. Wei (121882)
- Andrew Danks (121885)
- Ke Liu (121889)
- Wei Duan (101868)
Publication date
November 2012
DOIAbstract
<p>Mice bearing HT-29 xenografts were injected i.v. with saline, 5 mg/kg of free DOX, SCL-DOX or empty SCL twice a week for 3 weeks as indicated, starting on the day when tumor volume reached ∼35 mm<sup>3</sup>. Data shown are means ± S.E. (n = 5∼6). *, <i>P</i><0.05 compared to saline; **, <i>P</i><0.01 compared to saline; #, <i>P</i><0.05 compared to free DOX; &&, <i>P</i><0.01 compared to blank SCL; &&&, <i>P</i><0.001 compared to blank SCL.</p
Add to ORKG